Table 1.
Baseline clinical characteristics and TAVR procedural data from the coronary angiogram group and the PCI group.
| Angiogram group (n = 28) | PCI group (n = 13) | |
|---|---|---|
| Clinical characteristics | ||
| Age (years) | 72.54 ± 9.08 | 70.31 ± 7.99 |
| Male | 14 (50.0) | 9 (69.2) |
| Body mass index (kg/m2) | 28.94 ± 5.96 | 28.63 ± 5.38 |
| NYHA functional class III-IV | 17 (60.7) | 6 (46.2) |
| Diabetes | 13 (46.4) | 5 (38.5) |
| Hypertension | 24 (85.7) | 13 (100) |
| Coronary artery disease | 23 (82.1) | 13 (100) |
| Prior percutaneous coronary intervention | 15 (53.6) | 13 (100) |
| Prior coronary arterial bypass graft | 14 (50.0) | 9 (69.2) |
| History of atrial fibrillation | 4 (14.3) | 3 (23.1) |
| Peripheral vascular disease | 9 (32.1) | 7 (53.8) |
| Chronic obstructive pulmonary disease | 7 (25.0) | 5 (38.5) |
| Chronic kidney disease | 15 (53.6) | 10 (76.9) |
| eGFR (mL/min) | 60.36 ± 24.63 | 58.47 ± 26.01 |
| STS-PROM (%) | 5.25 ± 2.71 | 5.89 ± 3.06 |
| LogEuroSCORE (%) | 17.22 ± 11.79 | 17.45 ± 12.72 |
| Left coronary height (mm) | 12.77 ± 3.27 | 12.32 ± 2.72 |
| Right coronary height (mm) | 13.23 ± 3.20 | 14.50 ± 4.59 |
| Aortoventricular angulation (degrees) | 42.40 ± 7.97 | 43.30 ± 7.50 |
| Procedural characteristics | ||
| Success | 28 (100) | 13 (100) |
| Approach | ||
| Transfemoral | 8 (28.6) | 4 (30.8) |
| Nontransfemoral | 20 (71.4) | 9 (69.2) |
| Prothesis type | ||
| Edwards-SAPIEN | 12 (42.9) | 6 (46.2) |
| SAPIEN XT | 16 (57.1) | 7 (53.8) |
| Prothesis size (mm) | ||
| 23 | 15 (53.6) | 5 (38.5) |
| 26 | 11 (39.3) | 6 (46.2) |
| 29 | 2 (7.1) | 2 (15.4) |
| THV-coronary ostia position | ||
| Supra-ostial | 5 (17.8) | 3 (23.0) |
| Ostial level | 8 (28.6) | 5 (38.5) |
| Infra-ostial | 15 (53.6) | 5 (38.5) |
Variables are expressed as n (%) or mean ± SD. eGFR = estimated glomerular filtration rate; LogEuroSCORE = logistic EuroSCORE predicted risk of mortality; NYHA = New York Heart Association; STS-PROM = Society of Thoracic Surgeons Predicted Risk of Mortality; THV = transcatheter heart valve.